MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 215 filers reported holding MIRATI THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $15,582,000 | -24.4% | 200,000 | 0.0% | 2.88% | -35.7% |
| Q2 2019 | $20,600,000 | +89.8% | 200,000 | +35.0% | 4.48% | +99.9% |
| Q1 2019 | $10,856,000 | +28.0% | 148,100 | -26.0% | 2.24% | +100.9% |
| Q4 2018 | $8,484,000 | -49.6% | 200,000 | -44.1% | 1.12% | -55.0% |
| Q3 2018 | $16,846,000 | -66.5% | 357,672 | -64.9% | 2.48% | -68.7% |
| Q2 2018 | $50,295,000 | +13.5% | 1,020,178 | -29.3% | 7.92% | +14.6% |
| Q1 2018 | $44,329,000 | -0.8% | 1,443,948 | -41.0% | 6.91% | -5.4% |
| Q4 2017 | $44,671,000 | +53.3% | 2,447,746 | -1.7% | 7.30% | +69.4% |
| Q3 2017 | $29,142,000 | +220.6% | 2,490,801 | 0.0% | 4.31% | +290.5% |
| Q2 2017 | $9,091,000 | -16.4% | 2,490,801 | +19.1% | 1.10% | -16.2% |
| Q1 2017 | $10,872,000 | +177.1% | 2,090,801 | +153.1% | 1.32% | +202.1% |
| Q4 2016 | $3,924,000 | -40.6% | 826,001 | -17.4% | 0.44% | -26.4% |
| Q3 2016 | $6,610,000 | +74.5% | 1,000,000 | +44.1% | 0.59% | +60.9% |
| Q2 2016 | $3,788,000 | -8.7% | 693,863 | +257.9% | 0.37% | -8.2% |
| Q1 2016 | $4,149,000 | -44.3% | 193,863 | -17.8% | 0.40% | -12.4% |
| Q4 2015 | $7,453,000 | -26.8% | 235,870 | -20.2% | 0.46% | -19.1% |
| Q3 2015 | $10,178,000 | -10.1% | 295,700 | -17.8% | 0.57% | -6.9% |
| Q2 2015 | $11,319,000 | +26.0% | 359,661 | +17.4% | 0.61% | -13.1% |
| Q1 2015 | $8,985,000 | +31.3% | 306,463 | -17.1% | 0.70% | +134.9% |
| Q4 2014 | $6,844,000 | +111.6% | 369,512 | +100.0% | 0.30% | -12.1% |
| Q3 2014 | $3,235,000 | -56.2% | 184,756 | -50.0% | 0.34% | -6.9% |
| Q2 2014 | $7,390,000 | +109.8% | 369,512 | +100.0% | 0.36% | +6.7% |
| Q1 2014 | $3,523,000 | -1.2% | 184,756 | -13.8% | 0.34% | -27.4% |
| Q4 2013 | $3,564,000 | – | 214,286 | – | 0.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |